# Iguratimod as Treatment for Refractory Lupus Nephritis

> **NCT03054545** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Iguratimod

## Key facts

- **NCT ID:** NCT03054545
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-08
- **Primary completion:** 2018-05-08
- **Final completion:** 2019-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054545, "Iguratimod as Treatment for Refractory Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03054545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*